Cardiologists enthuse over Cordis' sirolimus trial results
This article was originally published in Clinica
Executive Summary
Final results of the pivotal US study for Cordis' sirolimus-eluting stent show that the device not only reduces the re-blockage of coronary arteries but ensures that a wide variety of at-risk patients can avoid the need to undergo future revascularisation.